Ignite Creation Date:
2024-05-05 @ 9:39 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00939770
Status:
COMPLETED
Last Update Posted:
2020-06-09
First Post:
2009-07-14
Brief Title:
Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Neuroblastoma |
| Recurrent Childhood Anaplastic Large Cell Lymphoma |
| Recurrent Malignant Solid Neoplasm |
| Recurrent Neuroblastoma |
| Refractory Anaplastic Large Cell Lymphoma |
| Refractory Malignant Solid Neoplasm |
Keywords: